{
  "version": "HEIM-CT v1.0",
  "generated": "2026-01-13T09:10:32.473994",
  "methodology": "HEIM Framework (Corpas et al. 2025)",
  "summary": {
    "total_trials": 563725,
    "trials_with_demographics": 75741,
    "diseases_analyzed": 89,
    "hic_lmic_ratio": 4.4,
    "gap_distribution": {
      "Critical": 89,
      "High": 0,
      "Moderate": 0,
      "Low": 0
    }
  },
  "enrollment_representation": {
    "white": {
      "observed_count": NaN,
      "observed_pct": 0,
      "reference_pct": 57.8,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 33217
    },
    "black": {
      "observed_count": NaN,
      "observed_pct": 0,
      "reference_pct": 12.1,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 32714
    },
    "asian": {
      "observed_count": NaN,
      "observed_pct": 0,
      "reference_pct": 5.9,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 32452
    },
    "hispanic": {
      "observed_count": NaN,
      "observed_pct": 0,
      "reference_pct": 18.7,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 24828
    },
    "american_indian": {
      "observed_count": 3145.0,
      "observed_pct": 0,
      "reference_pct": 0.7,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 109
    },
    "pacific_islander": {
      "observed_count": NaN,
      "observed_pct": 0,
      "reference_pct": 0.2,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 30590
    },
    "multiple": {
      "observed_count": 42039.0,
      "observed_pct": 0,
      "reference_pct": 10.7,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 319
    },
    "other": {
      "observed_count": NaN,
      "observed_pct": 0,
      "reference_pct": 3.9,
      "eri": 0.0,
      "status": "Severely underrepresented",
      "trial_count": 48925
    }
  },
  "geographic_distribution": {
    "hic_trials": 577613,
    "lmic_trials": 131557,
    "other_trials": 60924,
    "total_trials": 770094,
    "hic_percentage": 75.0,
    "lmic_percentage": 17.1,
    "hic_lmic_ratio": 4.4,
    "top_countries": [
      {
        "country": "United States",
        "trials": 192501
      },
      {
        "country": "China",
        "trials": 48028
      },
      {
        "country": "France",
        "trials": 41913
      },
      {
        "country": "Canada",
        "trials": 32892
      },
      {
        "country": "Germany",
        "trials": 29157
      },
      {
        "country": "United Kingdom",
        "trials": 29012
      },
      {
        "country": "Italy",
        "trials": 25614
      },
      {
        "country": "Spain",
        "trials": 25007
      },
      {
        "country": "Turkey (T\u00fcrkiye)",
        "trials": 22053
      },
      {
        "country": "South Korea",
        "trials": 17413
      },
      {
        "country": "Belgium",
        "trials": 15528
      },
      {
        "country": "Netherlands",
        "trials": 15516
      },
      {
        "country": "Egypt",
        "trials": 15202
      },
      {
        "country": "Denmark",
        "trials": 12774
      },
      {
        "country": "Australia",
        "trials": 12711
      },
      {
        "country": "Taiwan",
        "trials": 12455
      },
      {
        "country": "Brazil",
        "trials": 11718
      },
      {
        "country": "Poland",
        "trials": 11640
      },
      {
        "country": "Israel",
        "trials": 10888
      },
      {
        "country": "Switzerland",
        "trials": 10880
      }
    ]
  },
  "sponsor_diversity": {
    "NIH": {
      "trial_count": 10691,
      "with_demographics": 2257
    },
    "Industry": {
      "trial_count": 0,
      "with_demographics": 0
    },
    "Other": {
      "trial_count": 0,
      "with_demographics": 0
    }
  },
  "temporal_trends": {
    "2010": {
      "total_trials": 17506,
      "global_south_priority_trials": 6606,
      "gs_percentage": 37.7
    },
    "2011": {
      "total_trials": 18366,
      "global_south_priority_trials": 6749,
      "gs_percentage": 36.7
    },
    "2012": {
      "total_trials": 19438,
      "global_south_priority_trials": 7077,
      "gs_percentage": 36.4
    },
    "2013": {
      "total_trials": 20321,
      "global_south_priority_trials": 7201,
      "gs_percentage": 35.4
    },
    "2014": {
      "total_trials": 22624,
      "global_south_priority_trials": 7915,
      "gs_percentage": 35.0
    },
    "2015": {
      "total_trials": 24373,
      "global_south_priority_trials": 8796,
      "gs_percentage": 36.1
    },
    "2016": {
      "total_trials": 26448,
      "global_south_priority_trials": 9236,
      "gs_percentage": 34.9
    },
    "2017": {
      "total_trials": 27927,
      "global_south_priority_trials": 9687,
      "gs_percentage": 34.7
    },
    "2018": {
      "total_trials": 30103,
      "global_south_priority_trials": 10176,
      "gs_percentage": 33.8
    },
    "2019": {
      "total_trials": 31901,
      "global_south_priority_trials": 10769,
      "gs_percentage": 33.8
    },
    "2020": {
      "total_trials": 33393,
      "global_south_priority_trials": 14379,
      "gs_percentage": 43.1
    },
    "2021": {
      "total_trials": 38180,
      "global_south_priority_trials": 14251,
      "gs_percentage": 37.3
    },
    "2022": {
      "total_trials": 37117,
      "global_south_priority_trials": 12873,
      "gs_percentage": 34.7
    },
    "2023": {
      "total_trials": 38337,
      "global_south_priority_trials": 12614,
      "gs_percentage": 32.9
    },
    "2024": {
      "total_trials": 38595,
      "global_south_priority_trials": 12561,
      "gs_percentage": 32.5
    }
  },
  "disease_metrics_summary": {
    "critical_gap_count": 89,
    "high_gap_count": 0,
    "avg_ct_gap_score": 95.0,
    "global_south_priority_avg_gap": 95.0
  }
}